相似文献
1
Histone demethylases and cancer.
Adv Cancer Res. 2009;102:103-69. doi: 10.1016/S0065-230X(09)02004-1.
2
Histone lysine demethylases and their impact on epigenetics.
Cell. 2006 Apr 21;125(2):213-7. doi: 10.1016/j.cell.2006.04.003.
3
The emerging functions of histone demethylases.
Curr Opin Genet Dev. 2008 Apr;18(2):159-68. doi: 10.1016/j.gde.2007.12.003. Epub 2008 Feb 20.
4
The function and regulation of the JARID1 family of histone H3 lysine 4 demethylases: the Myc connection.
Cell Cycle. 2007 Jun 1;6(11):1324-8. doi: 10.4161/cc.6.11.4269. Epub 2007 Jun 14.
5
Role of hypoxia-inducible factors in epigenetic regulation via histone demethylases.
Ann N Y Acad Sci. 2009 Oct;1177:185-97. doi: 10.1111/j.1749-6632.2009.05027.x.
6
Transgenerational inheritance: how impacts to the epigenetic and genetic information of parents affect offspring health.
Hum Reprod Update. 2019 Sep 11;25(5):518-540. doi: 10.1093/humupd/dmz017.
7
The "Epigenetic Code Replication Machinery", ECREM: a promising drugable target of the epigenetic cell memory.
Curr Med Chem. 2007;14(25):2629-41. doi: 10.2174/092986707782023244.
8
Histone modifying enzymes: structures, mechanisms, and specificities.
Biochim Biophys Acta. 2009 Jan;1789(1):58-68. doi: 10.1016/j.bbagrm.2008.07.009. Epub 2008 Aug 3.
9
Dynamic regulation of histone lysine methylation by demethylases.
Mol Cell. 2007 Jan 12;25(1):1-14. doi: 10.1016/j.molcel.2006.12.010.
10
Histone modifications and cancer.
Adv Genet. 2010;70:57-85. doi: 10.1016/B978-0-12-380866-0.60003-4.
引用本文的文献
1
Histone Demethylase Modulation: Epigenetic Strategy to Combat Cancer Progression.
Epigenomes. 2023 May 17;7(2):10. doi: 10.3390/epigenomes7020010.
2
Structural analysis of the 2-oxoglutarate binding site of the circadian rhythm linked oxygenase JMJD5.
Sci Rep. 2022 Nov 30;12(1):20680. doi: 10.1038/s41598-022-24154-0.
3
Impact of on chromatin structure and histone methylation in malignant melanoma.
Int J Mol Med. 2022 May;49(5). doi: 10.3892/ijmm.2022.5122. Epub 2022 Mar 16.
4
IOX1 impedes host inflammation in imiquimod-triggered psoriasis.
Heliyon. 2021 Nov 19;7(11):e08433. doi: 10.1016/j.heliyon.2021.e08433. eCollection 2021 Nov.
5
The histone demethylase KDM2B activates FAK and PI3K that control tumor cell motility.
Cancer Biol Ther. 2020 Jun 2;21(6):533-540. doi: 10.1080/15384047.2020.1736481. Epub 2020 Mar 16.
6
Lysine demethylase 2 (KDM2B) regulates hippo pathway via MOB1 to promote pancreatic ductal adenocarcinoma (PDAC) progression.
J Exp Clin Cancer Res. 2020 Jan 15;39(1):13. doi: 10.1186/s13046-019-1489-0.
7
Chromatin Architecture as an Essential Determinant of Dendritic Cell Function.
Front Immunol. 2019 Jun 4;10:1119. doi: 10.3389/fimmu.2019.01119. eCollection 2019.
8
Pathogenic and Therapeutic Role of H3K4 Family of Methylases and Demethylases in Cancers.
Indian J Clin Biochem. 2019 Apr;34(2):123-132. doi: 10.1007/s12291-019-00828-x. Epub 2019 Apr 3.
9
Forskolin Sensitizes Human Acute Myeloid Leukemia Cells to H3K27me2/3 Demethylases GSKJ4 Inhibitor via Protein Kinase A.
Front Pharmacol. 2018 Jul 20;9:792. doi: 10.3389/fphar.2018.00792. eCollection 2018.
10
Modes of Interaction of KMT2 Histone H3 Lysine 4 Methyltransferase/COMPASS Complexes with Chromatin.
Cells. 2018 Mar 2;7(3):17. doi: 10.3390/cells7030017.
本文引用的文献
1
Ndy1/KDM2B immortalizes mouse embryonic fibroblasts by repressing the Ink4a/Arf locus.
Proc Natl Acad Sci U S A. 2009 Feb 24;106(8):2641-6. doi: 10.1073/pnas.0813139106. Epub 2009 Feb 6.
2
Dynamic Histone H1 Isotype 4 Methylation and Demethylation by Histone Lysine Methyltransferase G9a/KMT1C and the Jumonji Domain-containing JMJD2/KDM4 Proteins.
J Biol Chem. 2009 Mar 27;284(13):8395-405. doi: 10.1074/jbc.M807818200. Epub 2009 Jan 13.
3
Talk is cheap--cross-talk in establishment, maintenance, and readout of chromatin modifications.
Genes Dev. 2008 Dec 15;22(24):3375-82. doi: 10.1101/gad.1759708.
4
The lysine demethylase LSD1 (KDM1) is required for maintenance of global DNA methylation.
Nat Genet. 2009 Jan;41(1):125-9. doi: 10.1038/ng.268. Epub 2008 Dec 21.
5
Chromosomal rearrangements leading to MLL gene fusions: clinical and biological aspects.
Cancer Res. 2008 Dec 15;68(24):10024-7. doi: 10.1158/0008-5472.CAN-08-2208.
6
CDYL bridges REST and histone methyltransferases for gene repression and suppression of cellular transformation.
Mol Cell. 2008 Dec 5;32(5):718-26. doi: 10.1016/j.molcel.2008.10.025.
7
Ezh1 and Ezh2 maintain repressive chromatin through different mechanisms.
Mol Cell. 2008 Nov 21;32(4):503-18. doi: 10.1016/j.molcel.2008.11.004.
8
A jumonji (Jarid2) protein complex represses cyclin D1 expression by methylation of histone H3-K9.
J Biol Chem. 2009 Jan 9;284(2):733-9. doi: 10.1074/jbc.M804994200. Epub 2008 Nov 14.
9
Genomic loss of microRNA-101 leads to overexpression of histone methyltransferase EZH2 in cancer.
Science. 2008 Dec 12;322(5908):1695-9. doi: 10.1126/science.1165395. Epub 2008 Nov 13.
10
A role for mammalian Sin3 in permanent gene silencing.
Mol Cell. 2008 Nov 7;32(3):359-70. doi: 10.1016/j.molcel.2008.10.015.
Zotero 插件